StockData
Silo Pharma, Inc. logo

Silo Pharma, Inc. (SILO) stock

SILONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30
$1.71+0.14 (+8.57%)

Close on Nov 17, 2026Market cap $2.72MP/E –Yield –

Silo Pharma gross margin

Gross margin is gross profit as a percentage of revenue.

Silo Pharma's gross margin for the twelve months ending Jun 30, 2026 was -14.8%. For fiscal 2025 it was 38.6%, against 91.9% the year before. The highest annual figure on record is 91.9% in fiscal 2022.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202538.6%−53.3
FY2024Dec 31, 202491.9%+0.0
FY2023Dec 31, 202391.9%+0.0
FY2022Dec 31, 202291.9%+422.3
FY2020Dec 31, 2020-330.4%−362.9
FY2019Dec 31, 201932.5%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2026Mar 31, 2026-14.8%−106.7
Q4 FY2025Dec 31, 2025-14.8%−106.7
Q3 FY2025Sep 30, 2025-14.8%−106.7
Q2 FY2025Jun 30, 202591.9%+0.0
Q1 FY2025Mar 31, 202591.9%−0.0
Q4 FY2024Dec 31, 202491.9%+0.0
Q3 FY2024Sep 30, 202491.9%+0.0
Q4 FY2023Dec 31, 202391.9%−0.0
Q1 FY2023Jun 30, 202391.9%+67.6
Q4 FY2022Dec 31, 202291.9%+57.0
Q3 FY2022Sep 30, 202291.9%+648.4
Q2 FY2022Jun 30, 202291.9%+172.7
Q2 FY2021Jun 30, 202124.3%−15.5
Q1 FY2021Mar 31, 202134.9%−36.5
Q4 FY2020Dec 31, 2020-556.5%−588.7
Q3 FY2020Sep 30, 2020-80.8%−150.2
Q2 FY2020Jun 30, 202039.8%–
Q1 FY2020Mar 31, 202071.4%–
Q4 FY2019Dec 31, 201932.2%–
Q3 FY2019Sep 30, 201969.4%–

More Silo Pharma figures

See a number that looks wrong?